Who Should Be Screened for Wilson Disease in a Family?
At a Glance
If you are diagnosed with Wilson disease, all first-degree relatives—siblings, children, and parents—must be screened. Siblings have a 25% risk of having the disease. Early testing and preventative treatment can stop irreversible liver and neurological damage from copper buildup.
In this answer
4 sections
If you have just been diagnosed with Wilson disease, yes, your first-degree relatives—your siblings, children, and parents—should be tested [1][2]. Medical guidelines strongly recommend this process, known as “cascade screening,” because finding and treating the disease before symptoms appear can prevent irreversible liver and neurological damage [3][1][4]. Even if your family members feel completely healthy, they need to undergo a medical evaluation [5].
Understanding the Risk in Your Family
Wilson disease is an autosomal recessive genetic disorder [6][7]. This means that for someone to develop the disease, they must inherit two mutated copies of the ATP7B gene—one from each parent [8]. The parents are usually “carriers” who have only one mutated gene and do not have the disease themselves.
Because of how these genes are passed down, the risk varies depending on the relationship:
- Siblings: Your brothers and sisters have a 25% (1 in 4) chance of also having Wilson disease [5][9]. Because they share the same parents as you, the risk is highest for them.
- Children: Your children will automatically inherit one mutated gene from you, making them carriers. However, they will only develop Wilson disease if your partner also passes down a mutated gene [1][9].
- Partners: Because your children’s risk depends on both parents, your doctor may recommend testing your partner for carrier status [5][7]. If your partner is not a carrier, your children will not develop the disease, though guidelines may still require baseline screening for the children to be absolutely safe [1].
- Parents: While it is rare for a parent to have undetected Wilson disease (since they are typically just carriers), guidelines still recommend screening them [1][5].
How Are Family Members Screened?
The specific tests your family will need depend on whether the exact genetic mutations that caused your Wilson disease have been identified.
If your specific genetic mutations are known:
The most reliable approach for screening asymptomatic family members is genetic testing [5][10]. A simple blood or saliva test can check if your relatives share the exact same gene mutations that were found in you [1].
If your mutations are not known, or if genetic testing is unavailable:
Your family members will need a standard clinical workup to check how their bodies process copper and assess their liver health [11][12]. This typically includes:
- Blood tests: To measure levels of a copper-binding protein called ceruloplasmin and to check liver function enzymes [1].
- Urine tests: A 24-hour urine collection to measure how much copper is being excreted by the body [11].
- Physical exams: An evaluation by a doctor, which may include an eye exam by an ophthalmologist to look for Kayser-Fleischer rings (copper deposits in the eyes) and a neurological assessment [12].
A Reassuring Note About Treatment
If a family member is found to have Wilson disease through screening, doctors will typically initiate preventative treatment (such as zinc therapy) immediately, even if they feel perfectly fine and their current copper tests are normal [13][4]. Starting treatment early prevents the toxic build-up of copper and allows them to live a long, healthy, and normal life [4][14].
When Should Children Be Tested?
While siblings and parents should be tested as soon as possible after your diagnosis, the timeline for your children is a bit different. Screening for children typically begins around age 2 or 3 [5][1].
There are a few reasons for this slight delay:
- Wilson disease almost never causes symptoms or liver damage before this age [5].
- Diagnostic markers (like ceruloplasmin levels) are less reliable in infants, making test results difficult to interpret [1].
If your children are younger than 2 or 3, discuss a timeline with a pediatric hepatologist or geneticist to ensure they are tested at the right time.
Navigating Family Conversations
Talking to your family about genetic risk can be overwhelming. Consider asking your doctor to refer you to a genetic counselor. These specialists can help you navigate insurance coverage for your family members and explain the risks clearly. Additionally, you can ask your medical team for a “Family Letter”—a written document that you can hand directly to your relatives, explaining their risk and exactly what tests they need to ask their own doctors for.
Common questions in this guide
Which family members need to be tested for Wilson disease?
At what age should children be screened for Wilson disease?
What tests are used to screen family members for Wilson disease?
Will my partner need to be tested for Wilson disease?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What specific blood, urine, or genetic tests do my siblings and children need, and when should we schedule them?
- 2.Has my specific genetic mutation been identified so we know exactly what to test my family members for?
- 3.Should my partner undergo genetic testing to help clarify the specific risk to our children?
- 4.Can you refer us to a genetic counselor to help coordinate my family's testing and insurance approvals?
- 5.Do you have a "family letter" template I can use to explain the importance of screening to my relatives?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (14)
- 1
Population screening and diagnostic strategies in screening family members of Wilson's disease patients.
Li H, Tao R, Liu L, Shang S
Annals of translational medicine 2019; (7(Suppl 2)):S59 doi:10.21037/atm.2019.03.54.
PMID: 31179296 - 2
Familial screening of children with Wilson disease: Necessity of screening in previous generation and screening methods.
Li H, Liu L, Li Y, et al.
Medicine 2018; (97(27)):e11405 doi:10.1097/MD.0000000000011405.
PMID: 29979436 - 3
Wilson disease: a summary of the updated AASLD Practice Guidance.
Alkhouri N, Gonzalez-Peralta RP, Medici V
Hepatology communications 2023; (7(6)) doi:10.1097/HC9.0000000000000150.
PMID: 37184530 - 4
Subclinical neurological involvement does not develop if Wilson's disease is treated early.
Dubbioso R, Ranucci G, Esposito M, et al.
Parkinsonism & related disorders 2016; (24()):15-9.
PMID: 26851839 - 5
Are the new genetic tools for diagnosis of Wilson disease helpful in clinical practice?
Espinós C, Ferenci P
JHEP reports : innovation in hepatology 2020; (2(4)):100114 doi:10.1016/j.jhepr.2020.100114.
PMID: 32613181 - 6
Genetically Confirmed Wilson Disease: A Retrospective Cohort Study From Bahrain.
Isa HM, Alahmed FA, Busehail MY, et al.
Cureus 2024; (16(10)):e71805 doi:10.7759/cureus.71805.
PMID: 39559689 - 7
Genetic variation spectrum in ATP7B gene identified in Latvian patients with Wilson disease.
Zarina A, Tolmane I, Kreile M, et al.
Molecular genetics & genomic medicine 2017; (5(4)):405-409 doi:10.1002/mgg3.297.
PMID: 28717664 - 8
Wilson disease.
Członkowska A, Litwin T, Dusek P, et al.
Nature reviews. Disease primers 2018; (4(1)):21 doi:10.1038/s41572-018-0018-3.
PMID: 30190489 - 9
The dilemma to diagnose Wilson disease by genetic testing alone.
Stättermayer AF, Entenmann A, Gschwantler M, et al.
European journal of clinical investigation 2019; (49(8)):e13147 doi:10.1111/eci.13147.
PMID: 31169307 - 10
Diagnosis of Wilson disease.
Ferenci P
Handbook of clinical neurology 2017; (142()):171-180 doi:10.1016/B978-0-444-63625-6.00014-8.
PMID: 28433100 - 11
Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson's Disease.
Dong Y, Wang RM, Yang GM, et al.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021; (19(3)):590-596 doi:10.1016/j.cgh.2020.05.044.
PMID: 32485301 - 12
Minimal Criteria to Screen for Wilson Disease: A Delphi Consensus in the United States.
Bronstein JM, Gonzalez-Peralta RP, Lorincz M, et al.
International journal of hepatology 2025; (2025()):5525442 doi:10.1155/ijh/5525442.
PMID: 41210890 - 13
Zinc monotherapy for young children with presymptomatic Wilson disease: A multicenter study in Japan.
Eda K, Mizuochi T, Iwama I, et al.
Journal of gastroenterology and hepatology 2018; (33(1)):264-269 doi:10.1111/jgh.13812.
PMID: 28452067 - 14
Early Application of Auxiliary Partial Orthotopic Liver Transplantation in Murine Model of Wilson Disease.
Cheng Q, He SQ, Gao D, et al.
Transplantation 2015; (99(11)):2317-24 doi:10.1097/TP.0000000000000787.
PMID: 26018347
This information about Wilson disease family screening is for educational purposes only. Always consult a genetic counselor or hepatologist for specific screening and testing recommendations for your relatives.
Get notified when new evidence is published on Wilson disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.